Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 4
2013 5
2014 18
2015 20
2016 12
2017 12
2018 9
2019 7
2020 7
2021 14
2022 13
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Umeclidinium Bromide/Vilanterol Trifenatate (Anoro Ellipta).
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep. PMID: 30212060 Free Books & Documents. Review.
The objective of this review is to evaluate the beneficial and harmful effects of umeclidinium plus vilanterol (UMEC/VI) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema....
The objective of this review is to evaluate the beneficial and harmful effects of umeclidinium plus vilanterol (UMEC/VI) for the main …
Umeclidinium bromide/with vilanterol.
[No authors listed] [No authors listed] Aust Prescr. 2015 Apr;38(2):69-71. doi: 10.18773/austprescr.2015.027. Epub 2014 Dec 19. Aust Prescr. 2015. PMID: 26648622 Free PMC article. Review. No abstract available.
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H, Htet A, Moe S. Ni H, et al. Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD011897. doi: 10.1002/14651858.CD011897.pub2. Cochrane Database Syst Rev. 2017. PMID: 28631387 Free PMC article. Review.
OBJECTIVES: To assess the efficacy and safety of umeclidinium bromide versus placebo for people with stable COPD. SEARCH METHODS: We searched the Cochrane Airways Group Specialised Register (CAGR), ClinicalTrials.gov, the World Health Organization (WHO) trials porta …
OBJECTIVES: To assess the efficacy and safety of umeclidinium bromide versus placebo for people with stable COPD. SEARCH METHO …
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
Ismaila AS, Haeussler K, Czira A, Youn JH, Malmenäs M, Risebrough NA, Agarwal J, Nassim M, Sharma R, Compton C, Vogelmeier CF, Han MK, Halpin DMG. Ismaila AS, et al. Adv Ther. 2022 Sep;39(9):3957-3978. doi: 10.1007/s12325-022-02231-0. Epub 2022 Jul 17. Adv Ther. 2022. PMID: 35849317 Free PMC article. Review.
This network meta-analysis (NMA) investigated the comparative efficacy of single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus any triple (ICS/LABA/LAMA) combinations and dual therapies in patients with COPD. ...FF/UMEC/VI demonstrated statistical …
This network meta-analysis (NMA) investigated the comparative efficacy of single-inhaler fluticasone furoate/umeclidinium/vilanterol …
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.
Matera MG, Rogliani P, Rinaldi B, Cazzola M. Matera MG, et al. Expert Rev Clin Pharmacol. 2015 Jan;8(1):35-41. doi: 10.1586/17512433.2015.977256. Epub 2014 Nov 8. Expert Rev Clin Pharmacol. 2015. PMID: 25382021 Review.
In this article, we focus on the development of an inhaled fixed dose combination (FDC) of two 24-h bronchodilators, umeclidinium bromide and vilanterol (UMEC/VI) (ANORO). Several pivotal clinical trials have documented the impact of this combination on lung functio …
In this article, we focus on the development of an inhaled fixed dose combination (FDC) of two 24-h bronchodilators, umeclidinium …
Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease.
Kelly E. Kelly E. Expert Rev Clin Pharmacol. 2014 Jul;7(4):403-13. doi: 10.1586/17512433.2014.926812. Epub 2014 Jun 7. Expert Rev Clin Pharmacol. 2014. PMID: 24909949 Review.
Drugs from the two major classes of bronchodilator; umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long-acting beta2 agonist (LABA), have been combined in a single inhaler device for once-daily use in chronic obstructive pulmonary disease (COPD …
Drugs from the two major classes of bronchodilator; umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long- …
Fluticasone furoate, umeclidinium bromide, and vilanterol as a combination therapy for chronic obstructive pulmonary disease.
Parri G, Nieri D, Roggi MA, Vagaggini B, Celi A, Paggiaro P. Parri G, et al. Expert Rev Respir Med. 2018 Dec;12(12):997-1005. doi: 10.1080/17476348.2018.1548936. Epub 2018 Nov 28. Expert Rev Respir Med. 2018. PMID: 30463451 Review.
Areas covered: All 12-52 week-long studies comparing triple therapy with umeclidinium (UM) added to either fluticasone furoate/vilanterol (FF/VI) or fluticasone propionate/salmeterol (FP/SAL) vs. other comparators in COPD patients of group B or D (2011 GOLD classification) …
Areas covered: All 12-52 week-long studies comparing triple therapy with umeclidinium (UM) added to either fluticasone furoate/vilant …
Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review.
Spyratos D, Sichletidis L. Spyratos D, et al. Ther Clin Risk Manag. 2015 Mar 25;11:481-7. doi: 10.2147/TCRM.S67491. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 25848294 Free PMC article. Review.
This review focuses on published clinical trials about the fixed-dose combination of umeclidinium/vilanterol trifenatate in patients with COPD. Results from six studies (five of them of 12 weeks' duration and one that lasted 1 year, including more than 6,000 patients in to …
This review focuses on published clinical trials about the fixed-dose combination of umeclidinium/vilanterol trifenatate in patients …
Apremilast.
Cada DJ, Ingram K, Baker DE. Cada DJ, et al. Hosp Pharm. 2014 Sep;49(8):752-62. doi: 10.1310/hpj4908-752. Hosp Pharm. 2014. PMID: 25477601 Free PMC article.
The September 2014 monograph topics are tedizolid phosphate, ceritinib, omega-3-carboxylic acids, umeclidinium bromide inhalation powder, and siltuximab. The DUE/MUE is on avoidance of insulin use errors....
The September 2014 monograph topics are tedizolid phosphate, ceritinib, omega-3-carboxylic acids, umeclidinium bromide inhalat …
126 results

Searches related to "umeclidinium bromide"